Thursday, August 16, 2018
Company News: Page (1) of 1 - 01/10/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Regence BlueCross BlueShield of Utah and Aledade Partner to Expand Innovative Value-based Care Model

(January 10, 2018)

BETHESDA, Md., Jan. 10, 2018 (GLOBE NEWSWIRE) --

Today, Aledade, Inc. and Regence BlueCross BlueShield of Utah announced a new partnership expanding Aledade’s Utah Accountable Care Organization (ACO) to provide high-quality, coordinated care to 4,000 Regence plan members cared for by its practices. Under Aledade’s first commercial contract in the state, Regence and its members will benefit from Aledade’s innovative physician-led ACO model that rewards doctors for improving quality of care and patient health outcomes, while lowering costs.

"Utah has always been known for quality and innovation in healthcare. Aledade is proud to partner with Regence, a longtime leader in the state, to expand our unique primary care physician-led ACO model,” said Scott Segell, vice president at Aledade. “Regence members are the real beneficiaries of this partnership that allows independent primary care practices to take advantage of value-based opportunities with payers that have previously only been available to large physician networks and hospital providers.”

Aledade’s Utah ACO will take on accountability for the total health care experience of Regence members who see an ACO primary care physician. Aledade offers a new model of primary care by partnering with physicians to build and lead ACOs that allow doctors to stay independent, practice medicine like they’ve always wanted to, and thrive financially by keeping people healthy. In this partnership, Regence patients get to keep their primary care doctor while seeing the results of Aledade ACO practices’ focus on care coordination, population health management, and preventive care.

“We’re very pleased about our new collaboration with Aledade,” said Jim Swayze, president of Regence BlueCross BlueShield of Utah. “Their nationally deployed and proven ACO model aligns perfectly with our long-standing priority of working closely with leading provider groups who share our belief that Utahns deserve high quality, well-integrated health care at an affordable cost.”


Regence, Utah’s first health insurer, also has the distinction of being the first insurer to offer an accountable health solution, called Total Cost of Care, to the market in 2013. The inclusive care management model offers members the opportunity to align with their choice of physician groups, rather than requiring selection from a single system. Over the past five years, Regence BlueCross BlueShield of Utah and its affiliated health plans have implemented over 50 value-based agreements – including the Total Cost of Care program – with providers across Idaho, Utah, Oregon and Washington.


Founded in 2014, Aledade’s Accountable Care network has grown to include more than 260 independent, physician-led practices across 18 states that together represent more than 360,000 covered lives and $2.5 billion in health care spending. Aledade’s value-based primary care model now delivers care across all payer and patient populations, including Medicare, Medicare Advantage, Medicaid, and commercial health plans. Today, all of Aledade’s ACO partner practices offer same or next day appointments, and 95 percent provide access to on-call physicians 24 hours a day, 7 days a week.


Founded in 2014, Aledade offers a new model of primary care that puts physicians back where they should be: quarterbacking their patients’ health care. Aledade partners with primary care physicians to build and lead Accountable Care Organizations (ACOs) that allow these doctors to stay independent, practice medicine like they’ve always wanted to, and thrive financially by keeping people healthy. Aledade provides data analytics and user-friendly technology to help doctors provide more seamless care, unparalleled regulatory expertise, best practices developed with and shared by a national network of physicians, and face-to-face practice transformation support. Aledade has established successful ACOs that care for more than 360,000 patients in Arkansas, Delaware, Florida, Kansas, Louisiana, Maryland, Michigan, Mississippi, Missouri, New York, Pennsylvania, Tennessee, Utah, Virginia, and West Virginia, and has expanded to three new states – Ohio, Kentucky, and New Jersey – in 2018.


At the heart of the Aledade model is the simple, but radical, idea that Aledade only succeeds when partner practices succeed in delivering better care at a lower cost. For more information, visit

Regence BlueCross BlueShield of Utah, based in Salt Lake City, is the state’s first health insurer and now provides more than 529,000 members with comprehensive health insurance solutions. As a nonprofit independent licensee of the Blue Cross and Blue Shield Association, Regence is part of a family of companies dedicated to transforming health care by delivering innovative products and services that change the way consumers in Utah and nationwide experience health care. For more information, please visit,, or



A photo accompanying this announcement is available at


A photo accompanying this announcement is available at


A photo accompanying this announcement is available at

CONTACT: Lou RieplRegence BlueCross BlueShield of [email protected]

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  • Citius Pharmaceuticals Successfully Raises $10 Million

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines